CN103251649A - 人间充质干细胞培养上清液冻干粉及其制备方法 - Google Patents
人间充质干细胞培养上清液冻干粉及其制备方法 Download PDFInfo
- Publication number
- CN103251649A CN103251649A CN2013101337111A CN201310133711A CN103251649A CN 103251649 A CN103251649 A CN 103251649A CN 2013101337111 A CN2013101337111 A CN 2013101337111A CN 201310133711 A CN201310133711 A CN 201310133711A CN 103251649 A CN103251649 A CN 103251649A
- Authority
- CN
- China
- Prior art keywords
- stem cell
- lyophilized powder
- cell culture
- mesenchymal stem
- human mesenchymal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012228 culture supernatant Substances 0.000 title claims abstract description 43
- 239000008176 lyophilized powder Substances 0.000 title claims abstract description 40
- 238000004113 cell culture Methods 0.000 title claims abstract description 39
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 239000006228 supernatant Substances 0.000 claims abstract description 17
- 210000004027 cell Anatomy 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 239000006143 cell culture medium Substances 0.000 claims abstract description 5
- 238000012258 culturing Methods 0.000 claims abstract description 5
- 210000000130 stem cell Anatomy 0.000 claims description 34
- 230000003321 amplification Effects 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000000859 sublimation Methods 0.000 claims description 3
- 230000008022 sublimation Effects 0.000 claims description 3
- 230000004071 biological effect Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 description 6
- 108090000695 Cytokines Proteins 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 5
- 230000003796 beauty Effects 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 3
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 238000002316 cosmetic surgery Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000002734 Collagen Type VI Human genes 0.000 description 1
- 108010043741 Collagen Type VI Proteins 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310133711.1A CN103251649B (zh) | 2013-04-17 | 2013-04-17 | 人间充质干细胞培养上清液冻干粉的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310133711.1A CN103251649B (zh) | 2013-04-17 | 2013-04-17 | 人间充质干细胞培养上清液冻干粉的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103251649A true CN103251649A (zh) | 2013-08-21 |
CN103251649B CN103251649B (zh) | 2018-10-19 |
Family
ID=48956082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310133711.1A Active CN103251649B (zh) | 2013-04-17 | 2013-04-17 | 人间充质干细胞培养上清液冻干粉的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103251649B (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103550117A (zh) * | 2013-10-18 | 2014-02-05 | 上海润生生物技术有限公司 | 可促进皮肤修复与再生的美容护肤品及其制备方法和应用 |
CN104523753A (zh) * | 2015-01-22 | 2015-04-22 | 中国科学院广州生物医药与健康研究院 | 人脐带间充质干细胞培养上清活性因子及细胞裂解液的制备方法、产品与应用 |
CN104997708A (zh) * | 2015-07-07 | 2015-10-28 | 河南中科干细胞基因工程有限公司 | 干细胞条件培养基的获取及在防皮肤老化方面的应用 |
CN105055265A (zh) * | 2015-07-21 | 2015-11-18 | 北京博士园科技发展有限公司 | 一种美容养颜产品及其制备方法 |
CN106244652A (zh) * | 2016-08-17 | 2016-12-21 | 广州宏柯源生物科技有限公司 | 一种人间充质干细胞培养上清液冻干粉的制备方法及制得的冻干粉 |
CN106367386A (zh) * | 2016-10-14 | 2017-02-01 | 中卫华医(北京)生物科技有限公司 | 人脐带间充质干细胞因子冻干粉的制备方法 |
CN107260570A (zh) * | 2017-06-14 | 2017-10-20 | 南京仯素生物科技有限公司 | 一种间充质干细胞因子组合物及其制备方法和用途 |
CN108309921A (zh) * | 2017-12-21 | 2018-07-24 | 云南舜喜再生医学工程有限公司 | 一种富含细胞因子的冻干粉制备方法 |
CN109055308A (zh) * | 2018-08-21 | 2018-12-21 | 启迪汉洱康(嘉兴)生物科技有限公司 | 一种多肽混合原液的制备方法 |
CN109394563A (zh) * | 2018-11-06 | 2019-03-01 | 福建省海西细胞生物工程有限公司 | 一种干细胞培养基脂质体的制备方法及在护肤品中的应用 |
CN109627315A (zh) * | 2019-01-18 | 2019-04-16 | 广州润虹医药科技股份有限公司 | 脂肪间充质干细胞因子冻干粉及其制备方法 |
CN113041207A (zh) * | 2021-03-11 | 2021-06-29 | 浙江圣希澳医学科技有限公司 | 一种人间充质干细胞培养上清液冻干粉的制备及复苏方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101884602A (zh) * | 2010-03-03 | 2010-11-17 | 孙杰 | 一种皮肤美容修复抗衰除皱的化妆品制剂 |
CN101974486A (zh) * | 2010-11-25 | 2011-02-16 | 王泰华 | 从微量人脂肪组织提取间充质干细胞及规模化培养的方法 |
CN102068391A (zh) * | 2010-12-30 | 2011-05-25 | 广州赛莱拉化妆品科技有限公司 | 人干细胞生长因子在化妆品中的应用 |
CN102600057A (zh) * | 2012-03-16 | 2012-07-25 | 广州赛莱拉生物科技有限公司 | 人胎盘干细胞提取物冻干粉及其制备方法与应用 |
CN102732586A (zh) * | 2012-06-26 | 2012-10-17 | 亚太干细胞科研中心有限公司 | 一种间充质干细胞分泌素的培养方法 |
-
2013
- 2013-04-17 CN CN201310133711.1A patent/CN103251649B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101884602A (zh) * | 2010-03-03 | 2010-11-17 | 孙杰 | 一种皮肤美容修复抗衰除皱的化妆品制剂 |
CN101974486A (zh) * | 2010-11-25 | 2011-02-16 | 王泰华 | 从微量人脂肪组织提取间充质干细胞及规模化培养的方法 |
CN102068391A (zh) * | 2010-12-30 | 2011-05-25 | 广州赛莱拉化妆品科技有限公司 | 人干细胞生长因子在化妆品中的应用 |
CN102600057A (zh) * | 2012-03-16 | 2012-07-25 | 广州赛莱拉生物科技有限公司 | 人胎盘干细胞提取物冻干粉及其制备方法与应用 |
CN102732586A (zh) * | 2012-06-26 | 2012-10-17 | 亚太干细胞科研中心有限公司 | 一种间充质干细胞分泌素的培养方法 |
Non-Patent Citations (2)
Title |
---|
王亚平: "《干细胞衰老与疾病》", 31 July 2009 * |
范菊莉 等: "《人骨髓间充质干细胞的冷冻干燥实验》", 《第九届全国冷冻干燥学术交流会 中国上海》 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103550117A (zh) * | 2013-10-18 | 2014-02-05 | 上海润生生物技术有限公司 | 可促进皮肤修复与再生的美容护肤品及其制备方法和应用 |
CN104523753A (zh) * | 2015-01-22 | 2015-04-22 | 中国科学院广州生物医药与健康研究院 | 人脐带间充质干细胞培养上清活性因子及细胞裂解液的制备方法、产品与应用 |
CN104997708A (zh) * | 2015-07-07 | 2015-10-28 | 河南中科干细胞基因工程有限公司 | 干细胞条件培养基的获取及在防皮肤老化方面的应用 |
CN105055265A (zh) * | 2015-07-21 | 2015-11-18 | 北京博士园科技发展有限公司 | 一种美容养颜产品及其制备方法 |
CN106244652B (zh) * | 2016-08-17 | 2019-11-08 | 广州宏柯源生物科技有限公司 | 一种人间充质干细胞培养上清液冻干粉的制备方法及制得的冻干粉 |
CN106244652A (zh) * | 2016-08-17 | 2016-12-21 | 广州宏柯源生物科技有限公司 | 一种人间充质干细胞培养上清液冻干粉的制备方法及制得的冻干粉 |
CN106367386A (zh) * | 2016-10-14 | 2017-02-01 | 中卫华医(北京)生物科技有限公司 | 人脐带间充质干细胞因子冻干粉的制备方法 |
CN107260570A (zh) * | 2017-06-14 | 2017-10-20 | 南京仯素生物科技有限公司 | 一种间充质干细胞因子组合物及其制备方法和用途 |
CN107260570B (zh) * | 2017-06-14 | 2020-07-31 | 南京仯素生物科技有限公司 | 一种间充质干细胞因子组合物及其制备方法和用途 |
CN108309921A (zh) * | 2017-12-21 | 2018-07-24 | 云南舜喜再生医学工程有限公司 | 一种富含细胞因子的冻干粉制备方法 |
CN109055308A (zh) * | 2018-08-21 | 2018-12-21 | 启迪汉洱康(嘉兴)生物科技有限公司 | 一种多肽混合原液的制备方法 |
CN109394563A (zh) * | 2018-11-06 | 2019-03-01 | 福建省海西细胞生物工程有限公司 | 一种干细胞培养基脂质体的制备方法及在护肤品中的应用 |
CN109627315A (zh) * | 2019-01-18 | 2019-04-16 | 广州润虹医药科技股份有限公司 | 脂肪间充质干细胞因子冻干粉及其制备方法 |
CN109627315B (zh) * | 2019-01-18 | 2020-07-14 | 广州润虹医药科技股份有限公司 | 脂肪间充质干细胞因子冻干粉及其制备方法 |
CN113041207A (zh) * | 2021-03-11 | 2021-06-29 | 浙江圣希澳医学科技有限公司 | 一种人间充质干细胞培养上清液冻干粉的制备及复苏方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103251649B (zh) | 2018-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103251649A (zh) | 人间充质干细胞培养上清液冻干粉及其制备方法 | |
CN106244652B (zh) | 一种人间充质干细胞培养上清液冻干粉的制备方法及制得的冻干粉 | |
Mansilla et al. | Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries | |
CN101773688B (zh) | 一种含附属器的组织工程皮肤的制备方法 | |
CN101461772A (zh) | 用于美容护肤的干细胞分泌因子的制备方法 | |
CN103667187B (zh) | 一种人脂肪干细胞的分离培养方法和干细胞库的构建方法 | |
CN108004207B (zh) | 从脂肪中获取大量脂肪间充质干细胞的方法 | |
CN101914495A (zh) | 用于体外大量扩增毛囊干细胞的培养方法 | |
CN103074298B (zh) | 一种人脂肪间充质干细胞库及其构建方法 | |
CN104087551B (zh) | 一种体外分离培养人的表皮细胞的方法 | |
CN102676452A (zh) | 一种含人脐带间充质干细胞分泌液的培养基及其制备方法和应用 | |
CN102732586B (zh) | 一种间充质干细胞分泌素的制备方法 | |
CN107858329B (zh) | 从脂肪中分离脂肪间充质干细胞的方法和使用的试液 | |
CN104946585A (zh) | 一种人间充质干细胞培养液上清的生产方法及冻干方法及应用 | |
CN105820998A (zh) | 临床回输级细胞治疗用人脂肪干细胞ADSCs分离提取培养方法 | |
CN101922048A (zh) | 一种脐带间充质干细胞公共库的建库方法 | |
CN105112353A (zh) | 角质细胞和黑素细胞混合培养的方法及应用 | |
CN109453200A (zh) | 多组织来源的间充质干细胞裂解因子冻干粉的制备方法 | |
CN110448572A (zh) | 一种脐带间充质干细胞活性物与脐带血干细胞活性物的复合物的制备方法 | |
CN103898049A (zh) | 一种活细胞精华液产品及其制备方法和应用 | |
CN106924285A (zh) | 一种胎盘间充质干细胞注射液及其制备方法和应用 | |
CN105238749A (zh) | 一种复苏骨髓间充质干细胞的方法 | |
CN105969726A (zh) | 一种脂肪源干细胞提取制备方法 | |
CN108486050A (zh) | 从犬的脐带制备间充质干细胞的方法 | |
CN109718251A (zh) | 利用干细胞重建毛囊的生发方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: FENG WENFENG Free format text: FORMER OWNER: GUANGZHOU ETHICAL BIOTECHNOLOGY CO., LTD. Effective date: 20140428 Owner name: SHE ZHIYONG CHEN JIANXING FANG HAIQING Effective date: 20140428 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510070 GUANGZHOU, GUANGDONG PROVINCE TO: 510000 GUANGZHOU, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140428 Address after: 510000 Guangdong city of Guangzhou province Haizhuqu District Xiaogang Road No. 74 room 503 Applicant after: Feng Wenfeng Applicant after: She Zhiyong Applicant after: Chen Jianxing Applicant after: Fang Haiqing Address before: Guangzhou City, Guangdong province 510070 martyrs Road No. 76 Kiu building 13 Building G room Applicant before: Guangzhou Ethical Biotech Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |